Treatment of chronic myelogenous leukemia with bone marrow transplantation

D. S. Snyder, P. B. McGlave

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Chronic myelogenous leukemia is curable by bone marrow transplantation (BMT), especially when patients are treated while in the chronic phase. Bone marrow may be procured from histocompatible siblings, matched unrelated donors, or by autologous harvest with cryopreservation. Depletion of donor T cells may decrease the incidence of graft-versus-host disease, but leads to higher rates of relapse and graft failure. The malignant clone may persist or reappear at the molecular or chromosomal level without necessarily leading to clinical relapse after BMT.

Original languageEnglish (US)
Pages (from-to)535-557
Number of pages23
JournalHematology/Oncology Clinics of North America
Issue number3
StatePublished - 1990


Dive into the research topics of 'Treatment of chronic myelogenous leukemia with bone marrow transplantation'. Together they form a unique fingerprint.

Cite this